The open index of psychedelic research

Open datasets, papers, preregistrations, and trials from across psychedelic science.

11,281 records6 sources
Showing 1,273–1,296 of 11,281
ArticleMDMA

Integrated micro-solid-phase extraction with miniature mass spectrometry for on-site detection of illicit drugs in human hair.

Zhang Y, Zhang J, Wu J +10

Europe PMC2026
ArticlePsychedelics

Ten practical suggestions for setting up a psychedelic study.

Caulfield A, Butler M, Mehta MA

Europe PMC2026
PreprintPsychedelics

A Shared Entropic Axis Spans States of Consciousness Across Pharmacological and Clinical Conditions

Galvan Rial DS, Della Bella GA, Naci L +8

Europe PMC2026
TrialPsilocybin

Psilocybin-Assisted Therapy for Treatment-Resistant Depression in Bipolar II Disorder

ClinicalTrials.gov2026
ArticlePsilocybin

Music Playlist Use in Clinical Trials of Psychedelic Assisted Psychotherapy: A Systematic Review.

Cruz L, Beserra FR, Freind JMK +2

Europe PMC2026
PreregistrationPsilocybin

Psilocybin-Assisted Therapy for Common Mental Health Disorders and their Comorbid Presentations: A Scoping Review

OSF2026
ArticleKetamine

Acute Effects of Esketamine on the EEG Power Spectrum and Signal Complexity in Prolonged Disorders of Consciousness: A Prospective Exploratory Cohort Study.

Liang Y, Yang W, Wang X +8

Europe PMC2026
ArticleKetamine

Development and validation of a short-form (6-item) version of the clinician-administered dissociative states scale (CADSS-SF).

Taujanskaite VU, Kamboj SK

Europe PMC2026
ArticlePsychedelics

Dextromethorphan Beyond the Cough: Exploring Its Psychedelic Potential: A Systematic Review.

Willow E, Chaudhri A, Hasman L +3

Europe PMC2026
ArticleIbogaine

Tuning reductase activity in monoterpene indole alkaloid biosynthesis.

Carr SC, Wu S, Gase K +8

Europe PMC2026
Trial

A Prospective Randomized Non-inferiority Trial Comparing Anti-CD20 Maintenance Versus De-Escalation Strategy In Relapsing-Remitting Multiple Sclerosis

ClinicalTrials.gov2026
ArticleKetamine

Acute pretrauma ethanol exacerbates PTSD-like phenotype in rats and is reversed by early intranasal ketamine.

Yogev BE, Levi G, Efroni N +4

Europe PMC2026
ArticleKetamine

Effect of Perioperative Ketamine and Esketamine on Postoperative Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Al Subhi M, Al Yousufi M, Alnajdi H +4

Europe PMC2026
ArticlePsilocybin

Barriers and Facilitators for Psychedelic Research and Regulation in Brazil: Insights From Diverse Stakeholders.

Guimarães AL, Beserra FR, Cruz L +6

Europe PMC2026
ArticlePsilocybin

Balancing safety and access in Oregon's psilocybin services.

Cheung K, Propes C, Yaden DB

Europe PMC2026
ArticlePsilocybin

Genome-based optimization of psilocybin and N,N-dimethyltryptamine biosynthetic pathways in E. coli using CRISPR-associated transposases.

Abrahms ZN, Majdi M, Madsen SM +7

Europe PMC2026
ArticlePsilocybin

Acute Hallucinogen Intoxication Following Ingestion of a Commercially Available Mushroom Extract Product: A Case Report.

Udoro AJ, Yukyi Y, Ansari AZ +3

Europe PMC2026
ArticleLSD

Characterizing non-hallucinogenic psychedelics beyond the head twitch response: phenotypic fingerprinting of lisuride and LSD.

King JL, Effinger DP, Basquez-Pfeifer C +4

Europe PMC2026
ArticleKetamine

Ketamine and Evolving Neuroplasticity.

Prabakar A

Europe PMC2026
ArticleKetamine

Comparison of esketamine combined with dexmedetomidine versus propofol combined with midazolam on drug-induced sleep endoscopy: a randomized controlled trial.

Jiang Y, Wang Z, Wen H +7

Europe PMC2026
ArticleMDMA

Blinding, Expectancy, and the Active Placebo Paradox in MDMA Research.

Earleywine M, Allen Q

Europe PMC2026
PreregistrationPsychedelics

Self-compassion, compassion, psychedelics

OSF2026
ArticlePsychedelics

Patient-Driven Care in Psychedelic Therapy.

Zisman-Ilani Y, Yehuda R

Europe PMC2026
ArticlePsychedelics

Psychedelic Therapies in the United States - Balancing State and Federal Oversight.

Hughes M

Europe PMC2026